High Rates of Stroke History in Asymptomatic Atrial Fibrillation Patients

Screening is needed to identify atrial fibrillation patients with no symptoms so that stroke prevention treatment can be given.

Newly diagnosed patients with non-valvular atrial fibrillation have a five-fold increased risk of stroke compared to those without atrial fibrillation, according to a new study.

The results from the GLORIA-AF Registry presented today at EHRA EUROPACE - CARDIOSTIM 2017.The findings highlight the need for screening to identify atrial fibrillation patients with no symptoms so that stroke prevention treatment can be given.

Atrial Fibrillation - Causes, Symptoms, Diagnosis, Treatment, Complication, Risks
Atrial fibrillation may not be life-threatening in itself but it is important to understand the causes, symptoms and treatments because of the risk of life-threatening complications.

‘People with non-valvular atrial fibrillation with few or no symptoms are more likely to have had a stroke before diagnosis than symptomatic atrial fibrillation patients.’

"Strokes in patients with non-valvular atrial fibrillation tend to be particularly severe and disabling, with about half of patients dying within one year," said lead author Dr Steffen Christow, a cardiologist at Hospital Ingolstadt GmbH, Ingolstadt, Germany.

"Appropriate anticoagulant therapy substantially reduces the risk of stroke, but in many cases non-valvular atrial fibrillation is only diagnosed after a patient has had a stroke," he continued. "When patients are unaware of their atrial fibrillation they remain untreated and unprotected from a stroke."

GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a large, multinational, prospective registry program involving patients with newly diagnosed non-valvular atrial fibrillation. This sub-analysis compared characteristics between symptomatic and asymptomatic patients in Western Europe.

In United States Costs Soar For Atrial Fibrillation Hospitalizations
Research reveals that U.S. hospitalizations and costs of care for atrial fibrillation nearly doubled from 1998 to 2010.

The study included 6,011 consecutively enrolled patients with non-valvular atrial fibrillation in Western Europe. Symptom status was defined by the European Heart Rhythm Association (EHRA) score: I-II asymptomatic/minimally symptomatic; III-IV symptomatic.

A total of 4,119 patients (two-thirds) were asymptomatic/minimally symptomatic (hereafter referred to as 'asymptomatic') and one-third (1,892) were symptomatic at the time of diagnosis. A number of differences were observed between the two groups.

Delayed Use of Blood Thinners for Patients With Atrial Fibrillation Increases Dementia Risk
The risk of dementia in low-risk patients was 30% higher for those who received delayed treatment, and a significant 136% higher for high-risk patients.

In terms of medical history, asymptomatic patients were twice as likely to have permanent atrial fibrillation (15.8% versus 8.3%) and more than twice as likely to have had a previous stroke (14.7% versus 6.0%) than patients in the symptomatic group. Asymptomatic and symptomatic patients had a similar number of stroke risk factors, as indicated by a CHA2DS2-VASc score of 3.3 in each group.

Dr Christow said, "The finding of a higher rate of the previous stroke in the asymptomatic patients despite no differences in the number of stroke risk factors may be explained by a longer but undiagnosed history of atrial fibrillation."

New Guidelines on Atrial Fibrillation Launched
Atrial fibrillation is associated with a 1.5-2 fold increased the risk of death. By 2030,14-17 million cases of atrial fibrillation will be reported in Europe.

"Our study found that in Western Europe, two-thirds of patients newly diagnosed with atrial fibrillation were asymptomatic," he continued. "Without detection, patients may not receive appropriate preventive therapy and remain at increased risk of stroke."

Dr Christow concluded: "These results underline the urgent need for public programs to detect atrial fibrillation in the general population."

Source-Eurekalert